Histogenics Corp (HSGX) Is Too Cheap To Pass Up For Hedgie Hal Mintz

Page 4 of 9 – SEC Filing
12.
TYPE OF REPORTING PERSON (SEE INSTRUCTIONS)

OO
CUSIP No.
43358V1091.
NAME OF REPORTING PERSONSHal Mintz2.
CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (SEE INSTRUCTIONS)

(a) [_]

(b) [X]

3.
SEC USE ONLY4.
CITIZENSHIP OR PLACE OF ORGANIZATIONUSANUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH

5.
SOLE VOTING POWER06.
SHARED VOTING POWER 799,9317.
SOLE DISPOSITIVE POWER08.
SHARED DISPOSITIVE POWER 799,9319.
AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 799,93110.
CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN
SHARES (SEE INSTRUCTIONS)

[_]11.
PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)5.0212.
TYPE OF REPORTING PERSON (SEE INSTRUCTIONS)

IN?

CUSIP No.
43358V109

Item 1.
(a).
Name of Issuer:Histogenics Corporation

(b).
Address of issuer’s principal executive offices:830 Winter Street, 3rd Floor
Waltham, Massachusetts 02451

Item 2.
(a).
Name of person filing:Sabby Healthcare Master Fund, Ltd.
Sabby Volatility Warrant Master Fund, Ltd.
Sabby Management, LLC
Hal Mintz

Follow Ocugen Inc. (NASDAQ:OCGN)